2seventy bio and JW Therapeutics Announce Intent To Expand Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies and Autoimmune Therapies Sep 12, 2023 06:55AM
Medigene Receives $3 Million Milestone Payment from 2seventy bio Jan 18, 2023 11:35AM
2seventy bio and JW Therapeutics Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies Oct 27, 2022 07:00AM